Results 131 to 140 of about 13,054 (213)

Epigenetic regulation in cancer chemoresistance and combined therapeutic strategies. [PDF]

Front Cell Dev Biol
Jiang L, Yuan Y, Zhang D, Wang J, Jiang X, Shi Y.   +5 more
europepmc   +1 more source

Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors. [PDF]

ACS Pharmacol Transl Sci
Schäker-Hübner L, Hansen FK.
europepmc   +1 more source

Structural Characterization of Dual-Threat Pt-HDACi Anticancer Agents by Collision Induced Dissociation Tandem Mass Spectrometry

Platinum (Pt)-based complexes have been widely applied in cancer treatment, but their clinical utilization is limited by systemic toxicities and chemoresistance.
Bosri, Rabeya, Sanchez, Brenda
core  

Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions. [PDF]

Mol Biomed
Yang J, Zhang M, Zhong Y, Sun C, Zhuang J.   +4 more
europepmc   +1 more source

Unraveling the potential of sodium butyrate in combating nasopharyngeal carcinoma: a narrative review. [PDF]

Ann Med Surg (Lond)
Peng LP, Chen L, He JN, Yin SH.
europepmc   +1 more source

Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma. [PDF]

Nat Commun
Peng J, Yang J, Antonopoulou G, Fang R, Adhikari B, Vogt M, Wolf E, Sun C, Du S, Godfrey L, Gupta A, Trajkovic-Arsic M, Teichmann N, Grünwald BT, Krebs N, Steiger K, Mogler C, Althoff K, Wang X, Giglio G, Liffers ST, Savvatakis K, Braren R, Lawlor RT, Scarpa A, Behrens D, Lang KS, Cheung PF, Siveke JT.   +28 more
europepmc   +1 more source

Dual Role of LBH589 in Triple-Negative Breast Cancer: Inhibition of Tumor Growth and Enhancement of Antitumor Immunity. [PDF]

Cancer Rep (Hoboken)
Anjing L, Rong Y, Su X, Liang C, Jue H, Zhu C.   +5 more
europepmc   +1 more source

Acetylation modification in malignant progression and therapeutic resistance of gliomas. [PDF]

Front Cell Dev Biol
Zhang J, Wang M, Wang H, Jiang X, Zou H.
europepmc   +1 more source

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy. [PDF]

Cells
Hawash M.
europepmc   +1 more source

The Promising Role of New Generation HDACis in Anti-Cancer Therapies [PDF]

EBioMedicine, 2018
openaire   +2 more sources